Medical Weight Loss for Ames, Iowa Residents

Ames, Iowa residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Ames through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Follow-up that stays with you in Ames: your care does not end at the first visit, Dr. Sharma and our team check in by secure video as you progress, no matter where you are in Iowa. Results vary. Doctor review just $119 (medication separate).

Why Ames Residents Choose New Hope Weight Loss

We are built for people who would rather not deal with insurance at all. New Hope is cash-pay friendly, so there are no prior authorizations, no denials, and no waiting on a carrier to decide what you are allowed to try. Patients in Ames pay a flat physician fee of $119 and a clear monthly medication price, and we accept HSA, FSA, Klarna, and Affirm so the cost can fit your budget without a fight.

Ames is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.

The care you would find at our Costa Mesa clinic follows you home to Ames through telehealth, giving Iowa patients the same physician oversight without a single mile of travel. We care for patients throughout downtown Ames, the university area, and the greater Story County area. From your first question to your ongoing refills, the whole Iowa experience is built to feel personal, private, and genuinely supported.

Wherever you are in Ames or the wider Iowa area, the program reaches you the same way, with HSA, FSA, Klarna, and Affirm all accepted. For patients across Ames, compounded semaglutide starts at $166 per month, with a 90-day program available for $499, and the medication cost is kept separate from the $119 physician review. Wherever you are in Iowa, New Hope Weight Loss delivers physician-supervised GLP-1 programs by secure telehealth from our Costa Mesa, California clinic, with no office visit required.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset, from $166/mo

Most Ames patients start here. Semaglutide shares its active ingredient with Wegovy and Ozempic, and in branded-drug trials people lost an average of 15 to 17 percent of body weight. Our program runs $499 for 90 days, with Dr. Sharma adjusting your dose each month by telehealth. Results vary, and compounded semaglutide is not FDA-approved or brand-identical.

Tirzepatide, from $233/mo

Tirzepatide works on two hunger pathways at once, GLP-1 and GIP. In trials of the branded drug, qualified patients reached up to 22.5 percent body-weight loss, which is a high-dose figure and not typical. It shares its active ingredient with Mounjaro and Zepbound.

$119 physician review. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, with no surcharge for treating you in Ames by telehealth.

How Telehealth Works for Ames

The path from curious to treated is short, and it all runs through your screen. People in Ames start by completing a health-and-weight intake quiz online. Dr. Anjmun Sharma reviews every answer and meets you over secure video, usually within 48 hours, to talk through whether a compounded GLP-1 like semaglutide or tirzepatide fits your goals and history. When she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Ames home in cold-pack packaging designed to keep it stable. After that, you and Dr. Sharma stay connected through video follow-ups, so your progress is supported from any corner of .

Frequently Asked Questions, Ames

Can people from Ames get treated by New Hope Weight Loss?

Absolutely. We operate one physical clinic in Costa Mesa, California, and we provide telehealth care to Ames, Iowa. Whether you are in downtown Ames, the university area, and the greater Story County area or elsewhere in the area, the path is the same. Dr. Anjmun Sharma meets you by video and confirms if a compounded GLP-1 program is right for you.

Do Ames patients ever have to come into the office?

Never. Care is delivered entirely through telehealth, which means Ames residents stay home for consults, follow-ups, and questions. Once Dr. Sharma approves you, your compounded semaglutide or tirzepatide is mailed to Ames inside cold-pack packaging that holds the right temperature in transit.

What is the cost breakdown for Ames?

You pay $119 for the physician review. Semaglutide begins at $166 a month, or $499 across 90 days, and tirzepatide begins at $233 a month. Medication is a separate charge. We accept HSA, FSA, Klarna, and Affirm payments, and there is no distance surcharge applied to anyone in Ames.

What areas of Ames do you serve?

We serve patients from across Ames by telehealth, including downtown Ames, the university area, and the greater Story County area.

Is bilingual (Spanish) telehealth care available for Ames patients?

Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Ames patients.

Ames Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Ames, Iowa by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.